Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
- 13 August 2010
- journal article
- Published by Elsevier in The Lancet
- Vol. 376 (9739), 449-457
- https://doi.org/10.1016/s0140-6736(10)60666-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialThe Lancet, 2009
- The impact of gender and income on survival and retention in a South African antiretroviral therapy programmeTropical Medicine & International Health, 2009
- Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-AnalysisPLOS ONE, 2009
- Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland ComparedPLoS Medicine, 2008
- Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studiesAIDS, 2007
- Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalenceTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancerStatistics in Medicine, 2004
- A new measure of prognostic separation in survival dataStatistics in Medicine, 2004
- Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effectsStatistics in Medicine, 2002
- Prevalence and Cumulative Incidence of and Risk Factors for Anemia in a Multicenter Cohort Study of Human Immunodeficiency Virus–Infected and –Uninfected WomenClinical Infectious Diseases, 2002